The LionGlobal Singapore Trust stands out due to its strategic focus on Singapore, a hub of stability and growth in Asia. By investing in companies with strong local and regional ties, it offers exposure to a diversified mix of sectors, capitalizing on Singapore’s economic resilience. Its long-term growth strategy positions it well for sustained capital appreciation, even amidst market fluctuations

Have you ever heard of a company that is considered a "secret weapon" by the USA government and jokingly referred to by investors as the "Tesla of the data world"? That's right, it's Palantir Technologies (PLTR). Despite carrying the "mysterious label" since its inception, it has now caused a stir in the investment community. Some say it is the pioneer of the AI revolution, while others question whether it is an "overhyped stock". So, is PLTR an "upgrade" or a "gamble"? Today, let's talk about this company.
When talking about the "story" of PLTR, not mentioning its assistance to the USA government in epidemic prevention and control would be like talking about the Three-Body Problem without mentioning the Dark Forest. In 2020, using its Gotham platform, PLTR assisted the Centers for Disease Control and Prevention (CDC) in analyzing epidemic data and predicting epidemic trends in real-time. This not only saved countless lives but also showcased the enormous potential of data analysis in the public domain. Looking at the figures: In the 2023 fiscal year, PLTR achieved an 18% revenue growth rate, with free cash flow reaching 0.443 billion US dollars, accounting for a significant 22%. What's even more noteworthy is its profitability turnaround, shifting from previous losses to entering the GAAP profit phase, indicating that PLTR has found its rhythm in commercialization and sustainable development.
If PLTR is called the "Three-Body company" in the AI field, it is not an exaggeration. Why? Because it is both aloof and complex: its core technology is difficult to replicate...